Synonyms:vigabatrin, 4-aminohex-5-enoic acid, 60643-86-9, Sabril, 68506-86-5, 4-Amino-5-hexenoic acid, gamma-Vinyl GABA, Vigabatrine, 5-Hexenoic acid, 4-amino-, gamma-Vinyl-GABA, gamma Vinyl GABA, Vigabatrinum, MDL-71754, 4-Aminohexenoic acid, gamma-Vinyl-gamma-Aminobutyric Acid, RMI-71754, CPP-109, GVG, MDL 71,754, CPP109, (+/-)-Vigabatrin, VINYL GAMMA-AMINOBUTYRIC ACID, GR120KRT6K, (+/-)-gamma-Vinyl GABA, CHEMBL89598, DTXSID4041153, CHEBI:63638, Vigabatrine [French], Vigabatrinum [Latin], (+/-)-4-aminohex-5-enoic acid, Vigabatrina [Spanish], NCGC00016087-06, Vigabatrina, Sabrilex, Sabril (TN), Vigabatrin [USAN:INN:BAN], RMI-71890, MDL 71754, RMI 71754, 4-aminohex-5-enoic acid/S(+)-Gamma-VIGABATRIN, Hexenoic acid, 4-amino, SR-01000075653, UNII-GR120KRT6K, (+-)-gamma-Vinyl GABA, 4-Amino-hex-5-enoic acid, (+/-)-gamma-Vinyl-GABA, Kigabeq, rac-Vigabatrin, MFCD00274076, (1)-4-Aminohex-5-enoic acid, CPP 109, Vigabatrin [INN], Prestwick_837, EINECS 270-929-6, MFCD00274577, .gamma.-vinyl GABA, .gamma.-Vinyl-GABA, Spectrum_000368, 4-amino-5-hexenoicacid, SpecPlus_000664, VIGABATRIN [MI], (y)-gamma-Vinyl GABA, VIGABATRIN [JAN], Prestwick0_000501, Prestwick1_000501, Prestwick2_000501, Prestwick3_000501, Spectrum3_001825, VIGABATRIN [USAN], (?)-gamma-Vinyl GABA, VIGABATRIN [VANDF], Biomol-NT_000247, V 8261, VIGABATRIN [MART.], VIGABATRIN [USP-RS], VIGABATRIN [WHO-DD], Lopac0_001277, M071754, SCHEMBL26714, BSPBio_000421, BSPBio_003469, KBioSS_000848, Vigabatrin (JAN/USP/INN), (A+/-)-gamma-Vinyl GABA, DivK1c_006760, SPECTRUM1502036, (+/-)-?-Vinyl GABA, SPBio_002342, BPBio1_000465, BPBio1_000925, GTPL4821, DTXCID2021153, VIGABATRIN [ORANGE BOOK], Vinyl .gamma.-aminobutyric Acid, HSDB 8395, KBio1_001704, KBio2_000848, KBio2_003416, KBio2_005984, KBio3_002973, VIGABATRIN, (+/-)-, AMY6474, VIGABATRIN [EP MONOGRAPH], S(+)-4-AMINOHEXENOICACID, HMS1569F03, HMS2094M21, HMS2096F03, HMS3263P16, VIGABATRIN [USP MONOGRAPH], BCP16220, Tox21_110301, Tox21_501277, BDBM50118886, HB0868, AKOS015854596, CCG-205350, CS-0791, DB01080, LP01277, SDCCGSBI-0051243.P004, .gamma.-Vinyl-.gamma.-aminobutyric acid, NCGC00016087-03, NCGC00016087-04, NCGC00016087-05, NCGC00016087-07, NCGC00016087-08, NCGC00016087-09, NCGC00016087-11, NCGC00016087-22, NCGC00024802-02, NCGC00024802-03, NCGC00024802-04, NCGC00024802-05, NCGC00024802-06, NCGC00261962-01, AS-11778, HY-15399, SY263247, SBI-0051243.P003, ( inverted question mark)-gamma-Vinyl GABA, CAS-68506-86-5, DB-117820, AB00053309, EU-0101277, FT-0675811, FT-0675812, FT-0700968, gamma-Vinyl GABA; 4-Amino-5-hexenoic acid, C07500, D00535, EN300-245587, AB00053309_04, A853593, Q421663, Q-201924, SR-01000075653-1, SR-01000075653-4, SR-01000075653-6, BRD-A07893380-001-01-6, Z1255431434, Vigabatrin, European Pharmacopoeia (EP) Reference Standard, Vigabatrin, United States Pharmacopeia (USP) Reference Standard
Pubchem:PUBCHEM:5665
Id:326ea73f-22ce-59c9-a197-95eee209b667
Description:nan
